• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.49% Nasdaq Down1.26%

    Cardiome Pharma Corp. (CRME)

    -NasdaqCM
    8.77 Down 0.19(2.15%) 11:42AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 30,042   4,511   789  
    Cost of Revenue10,027  936   -  
    Gross Profit 20,015   3,575   789  
    Operating Expenses
    Research Development637  476  6,017  
    Selling General and Administrative33,813  16,446  9,463  
    Non Recurring -  2,701  10,040  
    Others2,150  649  1,229  
    Total Operating Expenses -  20,272  26,749  
    Operating Income or Loss (16,585) (16,697) (25,960)
    Income from Continuing Operations
    Total Other Income/Expenses Net(110)21,659  11,913  
    Earnings Before Interest And Taxes(16,695)4,962  (14,047)
    Interest Expense1,483  87  4,268  
    Income Before Tax(18,178)4,875  (18,315)
    Income Tax Expense49  102   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(18,227)25,607  (7,097)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (18,227) 4,773   (18,315)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (18,227) 4,773   (18,315)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.